PubRank

Jean Revuz

Author PubWeight™ 22.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol 2002 1.96
2 Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003 1.94
3 Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003 1.74
4 Back and face involvement in hidradenitis suppurativa. Dermatology 2010 1.41
5 French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003 1.11
6 Living with acne. A study of adolescents' personal experiences. Dermatology 2007 1.07
7 Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2006 1.04
8 Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol 2006 1.04
9 Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol 2011 0.97
10 Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. Arch Dermatol 2003 0.95
11 Thalidomide: an old drug with new clinical applications. Expert Opin Drug Saf 2004 0.93
12 Efalizumab-induced bullous pemphigoid. J Am Acad Dermatol 2010 0.88
13 Visibility of neurofibromatosis 1 and psychiatric morbidity. Arch Dermatol 2003 0.84
14 Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004 0.84
15 Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections. J Am Acad Dermatol 2007 0.84
16 Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis. Medicine (Baltimore) 2010 0.80
17 Creation of a tool to assess adherence to treatments for acne. Dermatology 2008 0.79
18 Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patients. Am J Med Genet A 2008 0.77
19 A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis. Chest 2014 0.77
20 Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology 2008 0.76
21 When drugs make patients worse. Acta Derm Venereol 2003 0.75
22 Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol 2007 0.75
23 Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology 2006 0.75
24 Severe sialadenitis: a new complication of drug reaction with eosinophilia and systemic symptoms. J Am Acad Dermatol 2004 0.75
25 Sneddon syndrome revealing dysfibrinogenemia. Int J Dermatol 2003 0.75
26 Lymph nodes in hidradenitis suppurativa. Dermatology 2009 0.75
27 Leg ulcer and Paget disease of the bone. Arch Dermatol 2005 0.75
28 Phenotypic Characterization of Patients with Hidradenitis Suppurativa. Dermatology 2016 0.75
29 The global dermatological village in Paris. Arch Dermatol 2002 0.75
30 [Epidemiology of tinea capitis. Five-year retrospective study in three hospitals in the Val de Marne]. Presse Med 2006 0.75
31 Factors influencing the clinical evaluation of facial acne. Acta Derm Venereol 2009 0.75
32 Tufted folliculitis of the scalp and treatment with cyclosporine. Arch Dermatol 2006 0.75
33 Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients. J Am Acad Dermatol 2003 0.75